8 Result(s)
-
Article
Open AccessCannabis use, abuse and dependence during the COVID-19 pandemic: a sco** review
The interaction between cannabis use or addiction and SARS-COV-2 infection rates and COVID-19 outcomes is obscure. As of 08/01/2022 among 57 evaluated epidemiological/clinical studies found in Pubmed-database,...
-
Article
Open AccessDo patients’ resilience and subjective illness representation predict the outcome of a routine inpatient treatment program of major depressive disorder?
Adopting a personalized medicine approach beyond genetic/epigenetic profiling within psychiatric diagnostic and treatment is challenging. For the first time, we studied the influence of two patient resources (...
-
Article
Open AccessCorrection to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
The original article can be found online.
-
Article
Open AccessResponse to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
-
Article
Open AccessComment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
-
Article
Open AccessGabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
Recent years have seen a dramatic escalation of off-label prescribing for gabapentin and pregabalin (gabapentinoids) owing in part to generic versions of each being released over the past two decades, but also...
-
Article
Open AccessErratum to: Recurrent purpura due to alcohol-related Schamberg’s disease and its association with serum immunoglobulins: a longitudinal observation of a heavy drinker
-
Article
Open AccessRecurrent purpura due to alcohol-related Schamberg’s disease and its association with serum immunoglobulins: a longitudinal observation of a heavy drinker
It is unusual for purpura to emerge as a result of drinking alcohol. Such a peculiarity was observed in a 55-year-old man with a 30-year history of heavy alcohol use.
